Morning Briefing
Summaries of health policy coverage from major news organizations
Sen. Manchin Shares Parents', Lawmakers' Concerns About EpiPen Pricing
The Wall Street Journal: Sen. Joe Manchin, Father Of Mylan’s CEO, Airs ‘Concerns’ About Drug Costs
In a statement more remarkable for who said it than for what he said, Sen. Joe Manchin (D., W. Va.) said he shares the concerns of other senators and the public about “skyrocketing prices of prescription drugs.” Sen. Manchin’s daughter is Heather Bresch, chief executive of Mylan NV and the central figure in the current national furor over the skyrocketing cost of Mylan’s auto-injector product called the EpiPen. (Burton, 8/25)
Politico: Manchin Shares 'Concerns' On Drug Prices Amid Daughter's Company Controversy
Sen. Joe Manchin said Thursday that he shares the concerns his colleagues have voiced about how a pharmaceutical company run by his daughter prices a life-saving medicine it produces. The West Virginia Democrat’s daughter is Heather Bresch, the CEO of Mylan, the company that makes the EpiPen, a product that delivers the life-saving drug epinephrine for people with allergies to bee stings or certain foods. Mylan has come under fire in recent days for raising the price of the EpiPen by 548 percent since it acquired the rights to the product in 2007. (Nelson, 8/25)
The Hill: Senator Responds To Criticism Of Daughter's EpiPen Company
Sen. Joe Manchin (D-W.Va.), whose daughter Heather Bresch is the CEO of the company that makes EpiPens, said Thursday that he shares his colleagues' concerns about the recent price hike in the emergency allergy medication. "I am aware of the questions my colleagues and many parents are asking, and frankly I share their concerns about the skyrocketing prices of prescription drugs," Manchin said in a statement. (Sullivan, 8/25)
